Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Ardea Biosciences, Inc.    RDEA   US03969P1075

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisionsForum 
Company
Sector
Biotechnology
Calendar
-
More about the company
Chart ARDEA BIOSCIENCES, INC.
Duration : Period :
Ardea Biosciences, Inc. Technical Analysis Chart | RDEA | US03969P1075 | 4-Traders
Full-screen chart
Financials ($)
Sales 2012 10,7 M
EBIT 2012 -144 M
Net income 2012 -
Finance 2012 31,2 M
Yield 2012 -
Sales 2013 100 M
EBIT 2013 -24,9 M
Net income 2013 -
Finance 2013 22,9 M
Yield 2013 -
PER 2012 -
PER 2013
EV / Sales 2012 107x
EV / Sales 2013 11,6x
Capitalization 1 178 M
More Financials
Latest news on ARDEA BIOSCIENCES, INC.
2012 AstraZeneca hungry to refill medicine cabinet
2012DJAstraZeneca Completes Acquisition of Ardea Biosciences
2012 GSK goes hostile with $2.6 billion Human Genome offer
2012 Biotech targets fight back as Big Pharma circles
2012 ARDEA BIOSCIENCES, INC.: Securities Lawyers at Goldfarb LLP Seeking More Money,..
2012 Warner Chilcott to explore sale of company
2012 ARDEA BIOSCIENCES, INC.: Law Office of Brodsky & Smith, LLC Announces Investiga..
2012DJPharma M&A Surge Spurred By Necessity And Opportunity
2012 AstraZeneca CEO quits as drug sales tumble
2012 Watson to buy Actavis for at least $5.6 billion
2012 ARDEA BIOSCIENCES, INC.: The Law Firm of Levi & Korsinsky, LLP Announces Invest..
2012 ARDEA BIOSCIENCES, INC.: Law Office of Brodsky & Smith, LLC Announces Investiga..
More news
Forum ARDEA BIOSCIENCES, INC.
Be the first to post a message on ARDEA BIOSCIENCES, INC.
Advertisement
Income Statement Evolution
Ardea Biosciences, Inc. : Income Statement Evolution
More Financials
EPS Revisions
Ardea Biosciences, Inc. : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF
My Watchlist|My Portfolio
4-traders.com :
About :
Copyright © 2013 Surperformance. All rights reserved.